Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;23(4):319-323.
doi: 10.1111/hiv.13260. Epub 2022 Feb 23.

High willingness to use injectable antiretroviral therapy among women who have been lost to follow-up from HIV programmes: A nested cross-sectional study

Eva Laker Agnes Odongpiny  1   2 , Fiona Cresswell  1   3   4 , Arnold Arinaitwe  1 , Vivian Nakate  1 , Joshua Kyenkya  1 , Mohammed Lamorde  1 , Catriona Waitt  1   5 , David Meya  1   6 , Agnes Kiragga  1
Affiliations

High willingness to use injectable antiretroviral therapy among women who have been lost to follow-up from HIV programmes: A nested cross-sectional study

Eva Laker Agnes Odongpiny et al. HIV Med. 2022 Apr.

Abstract

Objectives: Efforts to achieve zero transmission of HIV to infants born to women living with HIV in sub-Saharan African are undermined by high rates of loss to follow-up in prevention of vertical transmission (PVT) programmes. The fear of HIV status disclosure through the discovery of pill bottles at home is a major contributor. Injectable antiretroviral therapy (ART) has proved to be efficacious in clinical trials and is discreet, offering a potential solution. We investigated the knowledge and willingness to use injectable ART among women who were lost to follow-up from the PVT programme in Uganda.

Methods: Women were traced by nurse counsellors and knowledge and opinions relating to injectable ART, including willingness to use it when it becomes available, were collected. Generalized linear models were used to determine predictors of willingness to use injectable ART.

Conclusions: Among 1023 women registered between 2017 and 2019 under the PVT programmes in Kampala and Wakiso districts, Uganda, 385 (38%) were lost to follow-up from care and 22% of these (83/385) were successfully traced and interviewed. Only 25% (21/83) had heard of injectable ART. Over half (55%, 46/83) were very willing to use injectable ART, 40% (33/83) were somewhat willing and four (5%) were not willing. Those who associated ART tablets with disclosure risk were more willing to consider injectable ART (adjusted odds ratio = 4.21; 95% confidence interval: 1.45-12.19; p = 0.008). We report high willingness to use injectable ART associated with fears that ART tablets were a potential source of HIV status disclosure. Injectable ART could be a solution for women who have challenges with disclosure.

Keywords: HIV/AIDS; PVT programme; injectable ART; loss to follow-up; nursing; pregnant.

PubMed Disclaimer

References

REFERENCES

    1. UNAIDS. UNAIDS Data 2020. https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-bo.... Accessed May 15, 2021. 2020.
    1. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS (London, England). 2012;26(16):2039-2052.
    1. Okawa S, Chirwa M, Ishikawa N, et al. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia. BMC Pregnancy Childbirth. 2015;15(1):258.
    1. UNAIDS. UNAIDS data 2019. https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_.... 2019. Accessed February 05, 2021.
    1. Geng EH, Odeny TA, Lyamuya R, et al. Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in Eastern Africa: application of a sampling-based approach. Clin Infect Dis. 2016;62(7):935-944.

Publication types